Insights

AI Moving from Pilot to Embedded Practice — With a Governance Gap
Introduction Artificial Intelligence and Machine Learning are no longer distant promises in clinical research. For several years, AI has been discussed as a potential accelerator for clinical trials, often through
Featured Insights

The role of the Medical Monitor in Clinical Trials
Introduction Clinical trials play a fundamental role in the development of new medical products, but they also entail risks for participants. Ensuring patient safety and scientific integrity is essential, making

Protocol Complexity Is Becoming the Biggest Threat to Clinical Trial Performance
Introduction Over the past decade, clinical research has undergone a profound transformation: trial protocols have become so complex that they now represent one of the leading drivers of delays, cost overruns, and

Chronic Illness as the Epicenter of Pharmaceutical Innovation: From Symptom Management to System Recalibration
Introduction For much of the 20th century, the pharmaceutical industry’s most significant innovations targeted acute problems such as infections or pain. Today, the center of gravity has shifted. The bulk

The Role of the Biostatistician in Clinical Research: From Statistical Rigor to Strategic Insight
Introduction In the ecosystem of clinical research, the role of biostatisticians is both indispensable and frequently underestimated. Many clinicians and scientists still believe that statisticians become relevant only after data

Enhancing Clinical Trials through Public-Private Partnerships: Overcoming Challenges and Maximizing Impact
Introduction As clinical trials become longer, more complex, and more expensive, public–private partnerships (PPPs) have emerged as a strategic tool to support and accelerate their implementation. These collaborations are not

The Clinical Data Manager in Clinical Trials: A Strategic Role in a Transforming Landscape
Introduction In the contemporary clinical research environment, the Clinical Data Manager (CDM) plays a crucial and increasingly strategic role. As clinical trials expand in scale, complexity, and regulatory demands, the